7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Musculoskeletal Diseases D009140 2 associated lipids
Measles D008457 3 associated lipids
Malocclusion D008310 3 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Addison Disease D000224 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Hirsutism D006628 3 associated lipids
Mastocytoma D034801 3 associated lipids
Progeria D011371 3 associated lipids
Hearing Loss D034381 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Periapical Granuloma D010484 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Osteoarthritis D010003 4 associated lipids
Hypercalciuria D053565 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Biliary Atresia D001656 4 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Periapical Diseases D010483 4 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Diabetes Complications D048909 4 associated lipids
Tinnitus D014012 4 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Jaw Diseases D007571 4 associated lipids
Fractures, Bone D050723 4 associated lipids
Sclerosis D012598 5 associated lipids
Macular Degeneration D008268 5 associated lipids
Mandibular Diseases D008336 5 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Osteonecrosis D010020 5 associated lipids
beta-Thalassemia D017086 5 associated lipids
Calcinosis D002114 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Bone Neoplasms D001859 5 associated lipids
Hot Flashes D019584 5 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Graves Disease D006111 6 associated lipids
Malnutrition D044342 6 associated lipids
Acromegaly D000172 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Dyslipidemias D050171 7 associated lipids
Bone Resorption D001862 7 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Chronic Disease D002908 7 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Carcinosarcoma D002296 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Hepatitis C D006526 7 associated lipids
Obesity, Morbid D009767 8 associated lipids
Osteolysis D010014 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Arthralgia D018771 8 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Thyroid Diseases D013959 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bacteremia D016470 9 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Periodontal Pocket D010514 9 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Osteitis D010000 10 associated lipids
Vision Disorders D014786 10 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Hemophilia A D006467 10 associated lipids
Cardiomyopathies D009202 10 associated lipids
Thinness D013851 11 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Lu LY et al. Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. 2017 J. Orthop. Res. pmid:28248001
Choi EM et al. Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. 2017 Environ. Toxicol. pmid:28836330
Bergdolt S et al. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. 2017 PLoS ONE pmid:28614388
Spirlandeli AL et al. Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. 2017 Clinics (Sao Paulo) pmid:28492723
Liu J et al. MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. 2017 PLoS ONE pmid:28319142
Songia P et al. Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. 2017 Oxid Med Cell Longev pmid:28261377
Jia J et al. Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. 2017 Mol Med Rep pmid:28260003
Shetelig C et al. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. 2017 PLoS ONE pmid:28253327
Irtyuga O et al. NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. 2017 Biomed Res Int pmid:28246602
Yu M et al. Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. 2016 Apr-Jun J Cancer Res Ther pmid:27461682
Dela Cruz A et al. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27006198
Lis GJ et al. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. 2016 Pol. Arch. Med. Wewn. pmid:27003233
Li N et al. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. 2016 Pharmazie pmid:29441931
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Li J et al. Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. 2016 Mol Med Rep pmid:26647856
Cervellati C et al. Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. 2016 Oxid Med Cell Longev pmid:26635910
Wang S et al. Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. 2016 J Ethnopharmacol pmid:27109342
Shirakawa J and Kulkarni RN Novel factors modulating human β-cell proliferation. 2016 Diabetes Obes Metab pmid:27615134
Xing R et al. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. 2016 Int. J. Mol. Med. pmid:27599586
Yongdi L et al. [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27526445

Table of Content